Marketing Drugs: Debating the Real Cost. Concern About Close Ties Between Doctors and Pharmaceutical Firms Are Prompting New Financial Disclosure Laws and Education Efforts
State Legislatures 2008 September; 34(8): 26-29
Showing items related by title, author, creator and subject.
Shamasunder, Bhavna; Bero, Lisa (2002-08-14)Corporate diversification allows for well-hidden financial ties between pharmaceutical and tobacco companies, which can cause a conflict of interest in the development and marketing of pharmaceutical products. In our ...